journal article·2025-10-15

Hydrophobically Modified Paclitaxel Prodrug Enables Ultrahigh Drug Loading Driven by Polarity Redistribution

Zhaofan Yang, Bingxu Qi, Guanyu Jin, Wenye Tan, Lanqing Wang, Luyao Wang, Xin Gao, Lu Zhang, Yu Luo, Shixian Lv

Nano Letters· Volume 25· Issue 41
Publisher page

Abstract

Controllable drug loading and self-assembly behaviors are vital to clinical applications of nanomedicines. Achieving high drug loading capacity (DLC) and stable self-assembly remains a significant challenge for hydrophobic chemotherapeutics such as paclitaxel (PTX). In this study, we propose a prodrug design strategy that significantly enhances loading efficiency. Unlike free PTX, which tends to aggregate uncontrollably, the designed prodrugs spontaneously self-assemble into uniform nanoparticles (100-200 nm) with an ultrahigh DLC exceeding 78 wt %. Molecular dynamics simulations reveal that hydrophobic modifications induce intramolecular polarity redistribution, with alkyl chains embedding within the nanoparticle core while polar moieties orient outward, stabilizing the assembled structures. The strategy is further validated by rational prodrug design and comprehensive in vitro and in vivo antitumor evaluations. Overall, the design principles established here offer a simple and versatile platform for optimizing nanomedicine formulations and advancing the clinical translation of high-DLC PTX prodrug nanomedicines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Treatment and Pharmacology · Nanoparticle-Based Drug Delivery · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Materials Science and Engineering

Peking University

State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter

Chinese Academy of Sciences

University of the Chinese Academy of Sciences

Key Laboratory of Polymer Ecomaterials

Changchun Institute of Applied Chemistry, Chinese Academy of Sciences

Center of Excellence for Smart Health (KCSH)

King Abdullah University of Science and Technology (KAUST)

Shanghai Engineering Research Center of Pharmaceutical Intelligent Equipment, Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Non-coding RNA, Institute for Frontier Medical Technology

School of Chemistry and Chemical Engineering Shanghai University of Engineering Science

Funding

Haixi Institute, Chinese Academy of Sciences · National Key Research and Development Program of China · National Natural Science Foundation of China · Program of Yaoshan laboratory

References (20)

Show source-provided references
1. 10.2147/IJN.S13278010.2147/IJN.S132780 ↗
2. 10.1002/smll.20210146010.1002/smll.202101460 ↗
3. 10.1021/acs.chemrev.2c0076310.1021/acs.chemrev.2c00763 ↗
4. 10.1021/acs.chemrev.3c0006210.1021/acs.chemrev.3c00062 ↗
5. 10.1016/j.biomaterials.2022.12197510.1016/j.biomaterials.2022.121975 ↗
6. 10.1039/D1TB02165F10.1039/D1TB02165F ↗
7. 10.1021/acsami.1c1235310.1021/acsami.1c12353 ↗
8. 10.1016/j.jconrel.2017.03.39110.1016/j.jconrel.2017.03.391 ↗
9. 10.1021/acs.chemmater.0c0408010.1021/acs.chemmater.0c04080 ↗
10. 10.1021/acs.chemmater.6b0164110.1021/acs.chemmater.6b01641 ↗
11. 10.1002/anie.20200873210.1002/anie.202008732 ↗
12. 10.1021/acsnano.5c0620210.1021/acsnano.5c06202 ↗
13. 10.1021/nl502044x10.1021/nl502044x ↗
14. 10.1021/acs.bioconjchem.7b0076710.1021/acs.bioconjchem.7b00767 ↗
15. 10.1002/adts.20210039110.1002/adts.202100391 ↗
16. 10.1021/jacs.1c0533210.1021/jacs.1c05332 ↗
17. 10.1038/s41592-021-01098-310.1038/s41592-021-01098-3 ↗
18. 10.1016/j.bpc.2020.10642910.1016/j.bpc.2020.106429 ↗
19. 10.1021/acs.chemmater.3c0222510.1021/acs.chemmater.3c02225 ↗
20. 10.1080/10717544.2021.195810710.1080/10717544.2021.1958107 ↗